RxDoctor Payments Data

Sean Malone, MD

Internal Medicine · Salisbury, NCNPI 1912983420

Payments from drug & device makers

$745in general payments, 2019–2025

Across 45 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$129
  • Astellas Pharma US Inc$108
  • GSK$88
  • Daiichi Sankyo Inc.$74
  • Dexcom, Inc.$57
  • Abbott$53
  • plus $235 from 11 others

What the payments were for

  • Food & beverage$71696%
  • Education$294%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$745 in reported general payments places this provider in the 70th percentile of 3,302 internal medicine providers in North Carolina.

See all internal medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$87,925
Medicare patients
357
Services billed
1,385

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban54$46,927
JardianceEmpagliflozin18$24,811
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$14,487
MyrbetriqMirabegron13$5,971
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,608
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$1,874
Omeprazole126$1,786
Rivastigmine12$1,328
SynthroidLevothyroxine Sodium13$1,239
Duloxetine Hcl40$1,046
Atorvastatin Calcium102$1,036
Escitalopram Oxalate48$1,035
Gabapentin47$938
Levothyroxine Sodium105$887
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$742

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$41$46,92754 claims
GSKTrelegy Ellipta, Anoro Ellipta$88$20,09529 claims
Astellas Pharma US IncMyrbetriq$108$5,97113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,302 internal medicine providers in North Carolina.

Other internal medicine in Salisbury

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →